Elevated serum or CSF levels of interleukin-6 (IL-6) and S100B, a marker of astroglial activation and blood-brain barrier (BBB) disruption, were observed in several cases of post-COVID myoclonus and ataxia [10-12]. The gene discussed is S100B; the disease is Ataxia.